MB Financial Bank - Trust Department’s Takeda Pharmaceutical TAK Stock Holding History

MB Financial Bank - Trust Department’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$15K	Buy	+732	New	+$14.7K	﹤0.01%	264

Other funds holding TAK

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

MB Financial Bank - Trust Department's TAK Position: Q1 2019 in Review

MB Financial Bank - Trust Department opened a new position in Takeda Pharmaceutical (TAK) in Q1 2019: 732 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #264 among its holdings.

390 funds tracked by Wall St. Rank hold TAK as of Q1 2019.

MB Financial Bank - Trust Department held 732 shares of Takeda Pharmaceutical worth $15K as of Q1 2019.
Takeda Pharmaceutical was a new MB Financial Bank - Trust Department position in Q1 2019.
Takeda Pharmaceutical made up ﹤0.01% of MB Financial Bank - Trust Department's portfolio in Q1 2019, its #264 holding.
390 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2019.

Based on MB Financial Bank - Trust Department's 13F filing for Q1 2019, filed 5 Apr 2019.